Ronald E. Hempling

1.4k total citations
43 papers, 1.1k citations indexed

About

Ronald E. Hempling is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Ronald E. Hempling has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Reproductive Medicine, 16 papers in Surgery and 15 papers in Obstetrics and Gynecology. Recurrent topics in Ronald E. Hempling's work include Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (15 papers) and Lymphoma Diagnosis and Treatment (9 papers). Ronald E. Hempling is often cited by papers focused on Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (15 papers) and Lymphoma Diagnosis and Treatment (9 papers). Ronald E. Hempling collaborates with scholars based in United States and United Kingdom. Ronald E. Hempling's co-authors include M. Steven Piver, Fernando O. Recio, Gamal H. Eltabbakh, Trudy R. Baker, Kyu H. Shin, Leslie E. Blumenson, Deborah L. Driscoll, Jeffrey M. Goldberg, Michael L. Hicks and Bruce A. Fine and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Ronald E. Hempling

42 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronald E. Hempling United States	19	534	495	417	236	177	43	1.1k
Elizabeth Poynor United States	17	691 1.3×	1.0k 2.0×	659 1.6×	141 0.6×	296 1.7×	20	1.5k
Gökhan Tulunay Türkiye	22	782 1.5×	797 1.6×	537 1.3×	159 0.7×	176 1.0×	121	1.6k
Steven A. Vasilev United States	17	547 1.0×	468 0.9×	349 0.8×	90 0.4×	159 0.9×	46	1.1k
Charles Levenback United States	13	916 1.7×	398 0.8×	665 1.6×	124 0.5×	276 1.6×	17	1.3k
S. Camatte France	26	833 1.6×	1.4k 2.9×	686 1.6×	131 0.6×	205 1.2×	74	1.8k
Glenn McCluggage United Kingdom	8	451 0.8×	881 1.8×	588 1.4×	104 0.4×	239 1.4×	15	1.1k
Ronald S. Leuchter United States	18	668 1.3×	584 1.2×	822 2.0×	184 0.8×	254 1.4×	22	1.4k
Francesco Maneschi Italy	20	1.1k 2.1×	870 1.8×	505 1.2×	121 0.5×	194 1.1×	50	1.6k
Tzu-I Wu Taiwan	23	674 1.3×	503 1.0×	316 0.8×	188 0.8×	161 0.9×	56	1.4k
Beth E. Nelson United States	17	395 0.7×	539 1.1×	325 0.8×	94 0.4×	177 1.0×	27	895

Countries citing papers authored by Ronald E. Hempling

Since Specialization

Citations

This map shows the geographic impact of Ronald E. Hempling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald E. Hempling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald E. Hempling more than expected).

Fields of papers citing papers by Ronald E. Hempling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald E. Hempling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald E. Hempling. The network helps show where Ronald E. Hempling may publish in the future.

Co-authorship network of co-authors of Ronald E. Hempling

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald E. Hempling. A scholar is included among the top collaborators of Ronald E. Hempling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald E. Hempling. Ronald E. Hempling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eltabbakh, Gamal H., et al.. (1999). Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. Journal of Surgical Oncology. 70(1). 6–12. 115 indexed citations

Silver, David F., Ronald E. Hempling, Fernando O. Recio, M. Steven Piver, & Gamal H. Eltabbakh. (1998). Complications Related to Indwelling Caval Catheters on a Gynecologic Oncology Service. Gynecologic Oncology. 70(3). 329–333. 13 indexed citations

Eltabbakh, Gamal H., M. Steven Piver, Ronald E. Hempling, Bruce A. Werness, & Leslie E. Blumenson. (1998). Importance of lymph node metastases in primary peritoneal carcinoma. Journal of Surgical Oncology. 68(3). 144–148. 11 indexed citations

Piver, M.Steven, et al.. (1998). Prolonged Disease-Free Survival by Maintenance Chemotherapy among Patients with Recurrent Platinum-Sensitive Ovarian Cancer. Gynecologic Oncology. 71(2). 190–195. 18 indexed citations

Recio, Fernando O., M. Steven Piver, Ronald E. Hempling, Gamal H. Eltabbakh, & Seung S. Hahn. (1998). Laparoscopic-assisted application of interstitial brachytherapy for locally advanced cervical carcinoma: Results of a pilot study. International Journal of Radiation Oncology*Biology*Physics. 40(2). 411–414. 20 indexed citations

Eltabbakh, Gamal H., M.Steven Piver, Ronald E. Hempling, et al.. (1998). Correlation between Extreme Drug Resistance Assay and Response to Primary Paclitaxel and Cisplatin in Patients with Epithelial Ovarian Cancer. Gynecologic Oncology. 70(3). 392–397. 32 indexed citations

Eltabbakh, Gamal H., M. Steven Piver, Ronald E. Hempling, & Kyu H. Shin. (1997). Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: Report of a prospective trial. International Journal of Radiation Oncology*Biology*Physics. 38(2). 373–380. 123 indexed citations

Eltabbakh, Gamal H., et al.. (1997). Estrogen Replacement Therapy Following Oophorectomy in Women with a Family History of Ovarian Cancer. Gynecologic Oncology. 66(1). 103–107. 10 indexed citations

Piver, M. Steven, Gamal H. Eltabbakh, Ronald E. Hempling, Fernando O. Recio, & Leslie E. Blumenson. (1997). Two Sequential Studies for Primary Peritoneal Carcinoma: Induction with Weekly Cisplatin Followed by either Cisplatin–Doxorubicin–Cyclophosphamide or Paclitaxel–Cisplatin. Gynecologic Oncology. 67(2). 141–146. 29 indexed citations

10.

Hempling, Ronald E., et al.. (1997). The Addition of Bleomycin and Dose-Escalated Ifosfamide to the Combination of Cisplatin Plus Ifosfamide Does Not Improve Survival in Advanced or Recurrent Cervical Carcinoma. American Journal of Clinical Oncology. 20(3). 315–318. 6 indexed citations

11.

Cuenca, Rosa, et al.. (1996). Endometrial carcinoma associated with breast carcinoma: Low incidence with tamoxifen use. Cancer. 77(10). 2058–2063. 4 indexed citations

12.

Cuenca, Rosa, et al.. (1996). Endometrial carcinoma associated with breast carcinoma: Low incidence with tamoxifen use. Cancer. 77(10). 2058–2063. 30 indexed citations

13.

Recio, Fernando O., M. Steven Piver, Ronald E. Hempling, & Deborah L. Driscoll. (1996). Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer. 78(10). 2157–2163. 82 indexed citations

14.

Recio, Fernando O., M. Steven Piver, & Ronald E. Hempling. (1996). Pretreatment Transperitoneal Laparoscopic Staging Pelvic and Paraaortic Lymphadenectomy in Large (≥5 cm) Stage IB2 Cervical Carcinoma: Report of a Pilot Study. Gynecologic Oncology. 63(3). 333–336. 28 indexed citations

15.

Hempling, Ronald E., M. Steven Piver, & Trudy R. Baker. (1995). Impact on Progression-Free Survival of Adjuvant Cyclophosphamide, Vincristine, Doxorubicin (Adriamycin), and Dacarbazine (CYVADIC) Chemotherapy for Stage I Uterine Sarcoma. American Journal of Clinical Oncology. 18(4). 282–286. 25 indexed citations

16.

Fine, Bruce A., et al.. (1995). Severe radiation morbidity in carcinoma of the cervix: impact of pretherapy surgical staging and previous surgery. International Journal of Radiation Oncology*Biology*Physics. 31(4). 717–723. 61 indexed citations

17.

Fine, Bruce A., Trudy R. Baker, Ronald E. Hempling, & Marilyn Intengan. (1994). Pregnancy Coexisting with Serous Papillary Adenocarcinoma Involving both Uterus and Ovary. Gynecologic Oncology. 53(3). 369–372. 4 indexed citations

18.

Hicks, Michael L., Ronald E. Hempling, & M. Steven Piver. (1993). Vulvar carcinoma with 0.5 mm of invasion and associated inguinal lymph node metastasis. Journal of Surgical Oncology. 54(4). 271–273. 17 indexed citations

19.

Piver, M. Steven & Ronald E. Hempling. (1990). A prospective trial of postoperative vaginal radium/cesium for grade 1–2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial ivasion in surgical stage I endometrial adenocarcinoma. Cancer. 66(6). 1133–1138. 71 indexed citations

20.

Hempling, Ronald E., et al.. (1989). Rectal J-pouch reservoir to decrease the frequency of tenesmus and defecation in low coloproctostomy. Gynecologic Oncology. 34(3). 379–382. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact